Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Wells

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|July 1, 1981
Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthinesP Mushlin, R C Boerth, J N Wells
Biochemistry|March 26, 1985
Differences in the association of calmodulin with cyclic nucleotide phosphodiesterase in relaxed and contracted arterial stripsY Saitoh, J G Hardman, J N Wells
Molecular Pharmacology|July 1, 1981
Xanthine derivatives that selectively inhibit cyclic GMP hydrolysis potentiate cardiac contractile effects of isoproterenol but not those of bethanecolP Mushlin, R C Boerth, J N Wells
Molecular Pharmacology|May 1, 1991
A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscleT S Guthrie, J Tsuji, J N Wells
Cancer Nursing|August 15, 2001
Psychometric evaluation of Breast Health Behavior Questionnaire: Spanish versionJ N Wells, H A Bush, D Marshall
Journal of Medicinal Chemistry|November 1, 1974
Imidazole derivatives as inhibitors of cyclic nucleotide phosphodiesterasesR Buchman, P F Heinstein, J N Wells
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1986
Phorbol diesters alter the contractile responses of porcine coronary arteryJ R Miller, D J Hawkins, J N Wells
Molecular Pharmacology|May 1, 1994
A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand bindingC E Piersen, C D True, J N Wells
Molecular Pharmacology|May 1, 1994
125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptorC E Piersen, C D True, J N Wells
Biochemical Pharmacology|March 15, 1983
Xanthine accumulation by normal and SV40-transformed WI-38 fibroblastsG M Nemecek, R H Chamberlain, J N Wells
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|July 1, 1981
Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthinesP Mushlin, R C Boerth, J N Wells
Biochemistry|March 26, 1985
Differences in the association of calmodulin with cyclic nucleotide phosphodiesterase in relaxed and contracted arterial stripsY Saitoh, J G Hardman, J N Wells
Molecular Pharmacology|July 1, 1981
Xanthine derivatives that selectively inhibit cyclic GMP hydrolysis potentiate cardiac contractile effects of isoproterenol but not those of bethanecolP Mushlin, R C Boerth, J N Wells
Molecular Pharmacology|May 1, 1991
A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscleT S Guthrie, J Tsuji, J N Wells
Cancer Nursing|August 15, 2001
Psychometric evaluation of Breast Health Behavior Questionnaire: Spanish versionJ N Wells, H A Bush, D Marshall
Journal of Medicinal Chemistry|November 1, 1974
Imidazole derivatives as inhibitors of cyclic nucleotide phosphodiesterasesR Buchman, P F Heinstein, J N Wells
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1986
Phorbol diesters alter the contractile responses of porcine coronary arteryJ R Miller, D J Hawkins, J N Wells
Molecular Pharmacology|May 1, 1994
A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand bindingC E Piersen, C D True, J N Wells
Molecular Pharmacology|May 1, 1994
125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptorC E Piersen, C D True, J N Wells
Biochemical Pharmacology|March 15, 1983
Xanthine accumulation by normal and SV40-transformed WI-38 fibroblastsG M Nemecek, R H Chamberlain, J N Wells
Pageof 7